Merck Immunotherapy Drug Shines In Lung Cancer Study
Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later, compared with about half of people who only got chemotherapy.
Read more on NPR
April 17, 2018 at 04:43AM
Health Care
Thứ Tư, 18 tháng 4, 2018
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét